331 related articles for article (PubMed ID: 29142837)
1. Preoperative management in patients with Graves' disease.
Piantanida E
Gland Surg; 2017 Oct; 6(5):476-481. PubMed ID: 29142837
[TBL] [Abstract][Full Text] [Related]
2. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
3. A retrospective cohort study: do patients with graves' disease need to be euthyroid prior to surgery?
Al Jassim A; Wallace T; Bouhabel S; Majdan A; Hier M; Forest VI; Payne R
J Otolaryngol Head Neck Surg; 2018 May; 47(1):37. PubMed ID: 29784035
[TBL] [Abstract][Full Text] [Related]
4. Use of Adjunctive Therapy to Achieve Preoperative Euthyroidism in Graves' Disease: A Case Report.
Abdulghani Alghanim N; Alkahtani SM; Assari FS; Alnosaier SW; Bader RM; Elmahi IE; Hendaz MM; Alhefdhi A
Am J Case Rep; 2020 Aug; 21():e923342. PubMed ID: 32759886
[TBL] [Abstract][Full Text] [Related]
5. 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.
Kahaly GJ; Bartalena L; Hegedüs L; Leenhardt L; Poppe K; Pearce SH
Eur Thyroid J; 2018 Aug; 7(4):167-186. PubMed ID: 30283735
[TBL] [Abstract][Full Text] [Related]
6. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
[TBL] [Abstract][Full Text] [Related]
7. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
[TBL] [Abstract][Full Text] [Related]
8. Rapid preoperative blockage of thyroid hormone production / secretion in patients with Graves' disease.
Fischli S; Lucchini B; Müller W; Slahor L; Henzen C
Swiss Med Wkly; 2016; 146():w14243. PubMed ID: 26765838
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of single-session radiofrequency ablation (RFA) in rendering euthyroidism for persistent/relapsed Graves' disease, a pilot study.
Fung MHM; Lang BHH
Eur Radiol; 2023 Sep; 33(9):6534-6544. PubMed ID: 37036479
[TBL] [Abstract][Full Text] [Related]
10. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
11. Effect of Lugol's solution on
Chai J; Zhang R; Zheng W; Zhang G; Jia Q; Tan J; Meng Z; Wang R
Clin Exp Med; 2023 Jul; 23(3):825-831. PubMed ID: 35840869
[TBL] [Abstract][Full Text] [Related]
12. Advancing Preoperative Strategies for Thyroidectomy in Graves' Disease: A Narrative Review.
Elkhoury D; Patel P; Sastry S; Tajik A; Elkhoury C; Montalbano M
Cureus; 2023 Nov; 15(11):e48156. PubMed ID: 38046703
[TBL] [Abstract][Full Text] [Related]
13. Dose-Dependent Influence of Antithyroid Drugs on the Difference in Free Thyroxine Levels between Mothers with Graves' Hyperthyroidism and Their Neonates.
Iwaki H; Ohba K; Okada E; Murakoshi T; Kashiwabara Y; Hayashi C; Matsushita A; Sasaki S; Suda T; Oki Y; Gemma R
Eur Thyroid J; 2021 Jul; 10(5):372-381. PubMed ID: 34540707
[TBL] [Abstract][Full Text] [Related]
14. Rescue pre-operative treatment with Lugol's solution in uncontrolled Graves' disease.
Calissendorff J; Falhammar H
Endocr Connect; 2017 May; 6(4):200-205. PubMed ID: 28325735
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Plasma Exchange as a Bridging Therapy for the Definitive Treatment of a Patient with Graves' Disease and Methimazole-Induced Liver Injury.
Purnamasari D; Wildan A; Kurniawan J; Mulansari NA; Karim B; Danil Yulian E
Int J Endocrinol Metab; 2023 Jul; 21(3):e136608. PubMed ID: 38028251
[TBL] [Abstract][Full Text] [Related]
16. Effect of preoperative iodine in patients with Graves' disease controlled with antithyroid drugs and thyroxine.
Kaur S; Parr JH; Ramsay ID; Hennebry TM; Jarvis KJ; Lester E
Ann R Coll Surg Engl; 1988 May; 70(3):123-7. PubMed ID: 2457351
[TBL] [Abstract][Full Text] [Related]
17. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
Jukić T; Stanicić J; Petric V; Kusić Z
Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
[TBL] [Abstract][Full Text] [Related]
18. Significant cardiac disease complicating Graves' disease in previously healthy young adults.
Witczak JK; Ubaysekara N; Ravindran R; Rice S; Yousef Z; Premawardhana LD
Endocrinol Diabetes Metab Case Rep; 2020 Jan; 2020():. PubMed ID: 31967967
[TBL] [Abstract][Full Text] [Related]
19. Lugol's solution-induced painless thyroiditis.
Yang JW; How J
Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28620500
[TBL] [Abstract][Full Text] [Related]
20. Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study.
Glinoer D; de Nayer P; Bex M;
Eur J Endocrinol; 2001 May; 144(5):475-83. PubMed ID: 11331213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
